Margaret Hills

3.7k citations

41 papers · 2.4k indexed · h-index 22

Cancer Research top 1%
- Breast Cancer Treatment Studies 19
Oncology top 2%
- HER2/EGFR in Cancer Research 26
- Cancer-related Molecular Pathways 4
Genetics top 2%
- Estrogen and related hormone effects 18
Pathology and Forensic Medicine top 5%
- Breast Lesions and Carcinomas 5
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research 7
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 4
Reproductive Medicine
- Ovarian cancer diagnosis and treatment 3

Co-authors: Mitch Dowsett Janine Salter Ian E. Smith Simone Detre J. Michael Dixon Anthony Skene Roger A’Hern Geraldine Walsh
Cited by: Cancer Research Oncology Genetics
Journals: Journal of Clinical Oncology (3 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer Research (5 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Margaret Hills

41 papers receiving 2.4k citations

Peers

Countries citing papers authored by Margaret Hills

Since Specialization

Citations

This map shows the geographic impact of Margaret Hills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Hills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Hills more than expected).

Fields of papers citing papers by Margaret Hills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Hills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Hills. The network helps show where Margaret Hills may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Margaret Hills, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margaret Hills Line = papers co-authored together Margaret Hills links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015) Breast Cancer Research ·Judith M. Bliss,Holly Tovey,Abigail Evans,Chris Holcombe,Kieran Horgan,Elizabeth Mallon,Raghavan Vidya,Anthony Skene,Andrew Dodson,Margaret Hills,Simone Detre,Lila Zabaglo,Jane Banerji,Lucy Kilburn,James P. Morden,J.F.R. Robertson,Ian Smith,Mitch Dowsett,(unknown)	2023	6
2	Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study Breast Cancer Research ·Elena López‐Knowles,Simone Detre,Margaret Hills,Eugene F. Schuster,Maggie C.U. Cheang,Holly Tovey,Lucy Kilburn,Judith M. Bliss,J.F.R. Robertson,Elizabeth Mallon,Anthony Skene,Abigail Evans,Ian Smith,Mitch Dowsett	2022	5
3	Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer Breast Cancer Research ·Sunil Pancholi,Mariana Ferreira Leal,Ricardo Ribas,Nikiana Simigdala,Eugene F. Schuster,Sophie Château‐Joubert,Lila Zabaglo,Margaret Hills,Andrew Dodson,Qiong Gao,Stephen Johnston,Mitch Dowsett,Sabina Cosulich,Elisabetta Maragoni,Lesley‐Ann Martin	2019	12
4	Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study Clinical Cancer Research ·Martin Filipits,Urania Dafni,Michael Gnant,Varvara Polydoropoulou,Margaret Hills,Astrid Kiermaier,Evandro de Azambuja,Denis Larsimont,Federico Rojo,Giuseppe Viale,Masakazu Toi,Nadia Harbeck,Kathleen I. Prichard,Richard D. Gelber,Phuong Dinh,Dimitrios Zardavas,Brian Leyland‐Jones,Martine Piccart,Mitch Dowsett	2018	15
5	Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer Breast Cancer Research and Treatment ·Amna Sheri,Ian E. Smith,Margaret Hills,Robin L. Jones,Stephen Johnston,Mitch Dowsett	2017	10
6	Principal results of the cancer of the ovary abiraterone trial (CORAL): A phase II study of abiraterone in patients with recurrent epithelial ovarian cancer (CRUKE/12/052) Annals of Oncology ·Susana Banerjee,Lucy Kilburn,Rebecca Bowen,Holly Tovey,Marcia Hall,Stan B. Kaye,Gordon Rustin,Martin Gore,Jennifer McLachlan,Ayoma D. Attygalle,Nina Tunariu,João Paulo da Silveira Nogueira Lima,Peter Chatfield,Lisa K. Jeffs,Elizabeth Folkerd,Margaret Hills,Sophie Perry,Gerhardt Attard,Mitch Dowsett,Judith M. Bliss	2016	2
7	Case report: A rare case of eosinophilic cholecystitis presenting after talc pleurodesis for recurrent pneumothorax Respiratory Medicine Case Reports ·Jenny Caesar,Mark L. Jordan,Margaret Hills	2016	2
8	Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas Breast Cancer Research ·(unknown),Elena López‐Knowles,Qiong Gao,Maggie C.U. Cheang,James P. Morden,Joel S. Parker,Lesley‐Ann Martin,Isabel Pinhel,Fiona E. McNeill,Margaret Hills,Simone Detre,Maria Afentakis,Lila Zabaglo,Andrew Dodson,Anthony Skene,Chris Holcombe,J.F.R. Robertson,A. Ian Smith,Judith M. Bliss,Mitch Dowsett	2016	20
9	Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study British Journal of Cancer ·Belinda Yeo,Lila Zabaglo,Margaret Hills,Andrew Dodson,Ian Smith,Mitch Dowsett	2015	33
10	Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer Annals of Oncology ·Mónica Arnedos,S. Drury,Maria Afentakis,Roger A’Hern,Margaret Hills,Janine Salter,I. E. Smith,Jorge S. Reis‐Filho,Mitch Dowsett	2014	30
11	Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy Annals of Oncology ·Amna Sheri,Ian E. Smith,Stephen Johnston,Roger A’Hern,Ashutosh Nerurkar,Robin L. Jones,Margaret Hills,Simone Detre,Sarah E. Pinder,W. Fraser Symmans,Mitch Dowsett	2014	78
12	Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer British Journal of Cancer ·Sarah Barton,Lila Zabaglo,Roger A’Hern,Nicholas C. Turner,Thomas Ferguson,Suzanne C. O’Neill,Margaret Hills,Ian Smith,Mitch Dowsett	2012	50
13	ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer Breast Cancer Research ·Isabel Pinhel,Margaret Hills,Suzanne Drury,Janine Salter,G. Sumo,Roger A’Hern,Judith M. Bliss,Ivana Šestak,Jack Cuzick,Peter Barrett‐Lee,Adrian L. Harris,Mitch Dowsett,(unknown)	2012	49
14	A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer Clinical Cancer Research ·Monika Graeser,Afshan McCarthy,Christopher J. Lord,Kay Savage,Margaret Hills,Janine Salter,Nick Orr,Marina Parton,Ian E. Smith,Jorge S. Reis‐Filho,Mitch Dowsett,Alan Ashworth,Nicholas C. Turner	2010	222
15	Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer JNCI Journal of the National Cancer Institute ·Mitch Dowsett,Ian E. Smith,S. Ebbs,J. Michael Dixon,Anthony Skene,Roger A’Hern,Janine Salter,Simone Detre,Margaret Hills,Geraldine Walsh	2007	469
16	Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists Journal of Clinical Oncology ·Mitch Dowsett,Steve R. Ebbs,J. Michael Dixon,Anthony Skene,C.D.M. Griffith,Irene Boeddinghaus,Janine Salter,Simone Detre,Margaret Hills,S. Ashley,Stephen Francis,Geraldine Walsh,Ian E. Smith	2005	229
17	Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience Endocrine Related Cancer ·M Dowsett,S. Johnston,L-A Martin,Janine Salter,Margaret Hills,Simone Detre,M. Cristina Gutiérrez,S K Mohsin,Jianzhong Shou,D. Craig Allred,Rachel Schiff,C. K. Osborne,I. E. Smith	2005	33
18	Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status European Journal of Cancer ·J. Michael Dixon,J Jackson,Margaret Hills,Lorna Renshaw,David Cameron,Thomas Anderson,William R. Miller,Mitch Dowsett	2004	32
19	Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. PubMed ·Giles Davies,Janine Salter,Margaret Hills,Lesley‐Ann Martin,Nigel Sacks,Mitch Dowsett	2003	111
20	HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. PubMed ·Mitch Dowsett,Catherine Harper‐Wynne,Irene Boeddinghaus,Janine Salter,Margaret Hills,Mike J. Dixon,Steve R. Ebbs,G P Gui,N Sacks,I. E. Smith	2001	150

About Margaret Hills

Margaret Hills is a scholar working on Cancer Research, Oncology and Genetics, having authored 41 papers that have together received 2.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (26 papers), Breast Cancer Treatment Studies (19 papers), Estrogen and related hormone effects (18 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Breast Lesions and Carcinomas (5 papers), Advanced Breast Cancer Therapies (4 papers), Cancer-related Molecular Pathways (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.6k citations) and Genetics (772 citations). Margaret Hills has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Mitch Dowsett, Janine Salter, Ian E. Smith, Simone Detre, J. Michael Dixon, Anthony Skene, Roger A’Hern, Geraldine Walsh, Irene Boeddinghaus and S. Ebbs. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact